Brandywine Managers’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-26,127
| Closed | -$162K | – | 37 |
|
|
2024
Q2 | $162K | Hold |
26,127
| – | – | 0.17% | 35 |
|
|
2024
Q1 | $247K | Hold |
26,127
| – | – | 0.24% | 37 |
|
|
2023
Q4 | $176K | Hold |
26,127
| – | – | 0.19% | 41 |
|
|
2023
Q3 | $116K | Hold |
26,127
| – | – | 0.2% | 37 |
|
|
2023
Q2 | $86.2K | Hold |
26,127
| – | – | 0.06% | 47 |
|
|
2023
Q1 | $74.5K | Hold |
26,127
| – | – | 0.05% | 47 |
|
|
2022
Q4 | $190K | Hold |
26,127
| – | – | 0.66% | 36 |
|
|
2022
Q3 | $211K | Hold |
26,127
| – | – | 0.69% | 35 |
|
|
2022
Q2 | $128K | Hold |
26,127
| – | – | 0.31% | 41 |
|
|
2022
Q1 | $618K | Buy |
26,127
+847
| +3% | +$20K | 1.07% | 26 |
|
|
2021
Q4 | $447K | Buy |
25,280
+4,892
| +24% | +$86.5K | 0.51% | 36 |
|
|
2021
Q3 | $575K | Hold |
20,388
| – | – | 0.6% | 34 |
|
|
2021
Q2 | $214K | Hold |
20,388
| – | – | 0.24% | 44 |
|
|
2021
Q1 | $240K | Hold |
20,388
| – | – | 0.32% | 43 |
|
|
2020
Q4 | $239K | Hold |
20,388
| – | – | 0.33% | 40 |
|
|
2020
Q3 | $162K | Buy |
20,388
+5,000
| +32% | +$39.7K | 0.31% | 39 |
|
|
2020
Q2 | $281K | Hold |
15,388
| – | – | 1.15% | 32 |
|
|
2020
Q1 | $184K | Buy |
15,388
+4,000
| +35% | +$47.8K | 0.06% | 35 |
|
|
2019
Q4 | $189K | Sell |
11,388
-18,312
| -62% | -$304K | 0.06% | 48 |
|
|
2019
Q3 | $197K | Buy |
+29,700
| New | +$197K | 0.07% | 47 |
|